Zacks Investment Research downgraded shares of CATAMARAN CORP (CTRX) from OUTPERFORM to NEUTRAL on February 22, 2013, with a target price of $58.00.
Catamaran Corp. is engaged in providing pharmacy benefit management services and healthcare information technology solutions to the healthcare benefit management industry. It helps organizations and the communities they serve take control of prescription drug costs. The Company's customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third party health care plan administrators, and state and federal government entities. Catamaran Corp., formerly SXC Health Solutions Corp., is headquartered in Lisle, Illinois.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on CATAMARAN CORP (CTRX),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment